Align Technology, Inc. with ticker code (ALGN) have now 12 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between $350.00 and $215.00 suggesting an average analyst share price target price of $289.26. (at the time of writing). Given that the stocks previous close was at $214.92 this would indicate that there is a potential upside of 34.6%. Also worth taking note is the 50 day moving average now sits at $240.73 and the 200 day MA is $263.40. The total market capitalization for the company now stands at 15.95B. Currently the stock stands at: $213.57 USD
The potential market cap would be $21,471,163,156 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 36.26, revenue per share of $52.12 and a 6.94% return on assets.
Align Technology, Inc. is a medical device company. The Company is primarily engaged in the design, manufacture and marketing of Invisalign clear aligners for the treatment of malocclusions, or the misalignment of teeth, by orthodontists and general dental practitioners (GPs), Vivera retainers for retention, iTero intraoral scanners and services for dentistry, and exocad computer-aided design and computer-aided manufacturing (CAD/CAM) software. It operates through two segments: Clear Aligner and Imaging Systems and CAD/CAM Services (Systems and Services). Its Clear Aligner segment consists of Comprehensive Products, which includes Invisalign Comprehensive and Invisalign First; Non-Comprehensive Products, which includes Invisalign Moderate, Lite and Express packages and Invisalign Go, and Non-Case products, which include retention products, Invisalign training, adjusting tools used by dental professionals. Its Systems and Services segment consists of iTero intraoral scanning systems.
